We can’t show the full text here under this license. Use the link below to read it at the source.
Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology
Molecular system analysis of two Alzheimer’s mouse models reveals shared features with human Alzheimer's brain changes
AI simplified
Abstract
Differential gene expression analysis identified significant alterations in APP/Aβ metabolism in two distinct mouse models of Alzheimer's disease.
- Two mouse models expressing different mutant AD-related proteins exhibited distinct pathophysiological features.
- One model developed amyloid beta oligomers without fibrillar amyloid deposits, while the other accumulated fibrillar amyloid and plaques.
- Integrative genomic analysis revealed alterations in pathways related to neurogenesis, cytoskeletal organization, and extracellular matrix regulation.
- FMR1 was identified as a key negative regulator of APP translation and oligomer formation.
- Transcriptomic findings displayed significant similarities with human Alzheimer's disease gene networks and dysregulated pathways.
AI simplified
Key numbers
354
Differentially Expressed Genes in Fibrillogenic Model
Identified in the dentate gyrus vs. wild-type mice.
22
Differentially Expressed Genes in Oligomerogenic Model
Identified in the entorhinal cortex vs. wild-type mice.